✦ LIBER ✦

Nafamostat Mesilate for Prevention of Post-ERCP Pancreatitis

✍ Scribed by Kyo-Sang Yoo; Won Sub Choi; Yong Woo Chung; Kyoung Oh Kim; Cheol Hee Park; Taeho Hahn; Sang Hoon Park; Jong Hyeok Kim; Jin Lee; Choong Kee Park

Book ID: 119245950
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 47 KB
Volume: 67
Category: Article
ISSN: 1097-6779
DOI: 10.1016/j.gie.2008.03.325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nafamostat Mesilate for Prevention of Po

Nafamostat Mesilate for Prevention of Post-ERCP Pancreatitis

✍ Kyo-Sang Yoo; Joon Ho Moon; Kwang Hyuk Park; Yong Woo Chung; Kyoung Oh Kim; Cheo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Nafamostat Mesilate in the Prevention of

Nafamostat Mesilate in the Prevention of Post-ERCP Pancreatitis and Risk Factors for Post-ERCP Pancreattis

✍ Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Chan Ho Park; Yong Mock Bae; Sa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Nafamostat mesylate in the prevention of

Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis

✍ Cheol Woong Choi; Dae Hwan Kang; Gwang Ha Kim; Jae Sup Eum; Sun Mi Lee; Geun Am 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Prevention of post-ERCP pancreatitis

✍ Gregory B. Haber 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 26 KB

Mo1427 The Efficacy of High Dose Nafamos

Mo1427 The Efficacy of High Dose Nafamostat Mesylate for the Prevention of Post-ERCP Pancreatitis

✍ Su Bum Park; Kee Tae Park; Dae Hwan Kang; Hyung Wook Kim; Cheol Woong Choi; Tae 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Use of Nafamostat Mesilate and Gabexate

Use of Nafamostat Mesilate and Gabexate Mesylate in the Prevention of Post-ERCP Pancreatitis and Risk Factor Analysis: A Prospective, Randomized Trial

✍ Cheol Woong Choi; Dae Hwan Kang; Gwang-Ha Kim; Geun-Am Song; Jae-Sup Eum; Sang-Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB